Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
W. Waggoner, L.R. Boots, R. Azziz.
Total testosterone and DHEAS levels as predictors of androgen-secreting neoplams: a population study.
Gynecol Endocrinol, 13 (1999), pp. 394-400
[2.]
Copeland.
Ginecología, pp. 405-437
[3.]
D. Dewailly, D. Deroubaix, C. Decanter, C. Cortet-Rudelli.
Hiperandrogénie et syndrome de virilisation chez la femme.
Encycl Méd Chir, Gynécologie, 146-F-10, (1999), pp. 11
[4.]
X. Matias-Guiu, J. Prat.
Anatomía patológica de los estados hiperandrogénicos.
Cuadernos de Medicina Reproductiva, 2 (1996), pp. 61-76
[5.]
M.C. Hayes, R.E. Scully.
Ovarian steroid cell tumors (not otherwise specified): a clinicopathologic analysis of 63 cases.
Am J Surg Pathol, 11 (1987), pp. 835-845
[6.]
H.C. Taylor, I. Pillay, S. Setrakian.
Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Mayo Clinic Proc, 75 (2000), pp. 288-292
[7.]
S. Duun.
Bilateral virilizing hilus (Leydig) cell tumors of the ovary.
Acta Obstet Scand, 73 (1994), pp. 76-77
[8.]
E.S. Surrey, D. De Siegler, J.C. Gambone, H.L. Judd.
Preoperative localization of androgen-secreting tumors: Clinical, endocrinologic and radiologic evaluation of ten patients.
Am J Obstet Gynecol, 158 (1988), pp. 1313-1322
[9.]
J.B. Russel, S.J. Lambert, K.J. Taylor, A.H. De Chemey.
Detection in a postmenopausal woman by duplex Doppler scanning.
Jama, 257 (1987), pp. 962-963
[10.]
R.A. Lobo.
Ovarian hyperandrogenism and androgen-producing tumors.
Endocrinol Metab Clin North Am, 20 (1991), pp. 773-805
[11.]
C. Bricaire, A. Raynaud, A. Benotmane, F. Clair, B. Paniel, I. Mowszowicz, et al.
Selective venous catheterization in the evaluation of hyperandrogenism.
J Endocrinol Invest, 14 (1991), pp. 949-956
[12.]
M.J. Picón, J.I. Lara, J.L. Sarasa, J. Díaz Recasens, R. Clouet, M.A. Gonzalo, et al.
Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour.
Eur J Endocrinol, 142 (2000), pp. 619-622
[13.]
L. Kennedy, A.I. Traub, A.B. Atkinson, B. Sheridan.
Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor.
J Clin Endocrinol Metab, 64 (1987), pp. 1320-1322
[14.]
A. Chico, J.L. García, X. Matías-Guiu, S.M. Webb, J. Rodríguez, J. Prat, et al.
A gonadotropin dependent stromal luteoma: a rare cause of post-menopausal virilization.
Clin Endocrinol (Oxf), 43 (1995), pp. 645-649
[15.]
H.B. Taylor, H.J. Norris.
Lipid cell tumors of the ovary.
Cancer, 20 (1967), pp. 1953-1962
[16.]
P.D. Silva, M.L. Sorensen, R. Reynertson, R.L. Virata, G.H. Mahairas.
Laparoscopic removal of virilizing hiliar cell tumor in a postmenopausal patient.
J Am Assoc Gynecol Laparosc, 4 (1997), pp. 499-502
[17.]
G. Baiocchi, N. Manci, G. Angeletti, R. Celleno, D. Fratini, G. Gilardi.
Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
Gynecol Obstet Invest, 44 (1997), pp. 141-144
[18.]
F.J. Hayes, K. Sheahan, S. Rajendiran, T.J. McKenna.
Virilization in a postmenopausal woman as result of hilus cell hyperplasia associated with ovarian cyst.
Am J Obstet Gynecol, 176 (1997), pp. 719-720
[19.]
G. Abrahamsson, A. Norstrom, M. Hahlin, F. Knutsson, P.O. Janson.
Steroid prodution and gonadotropin sensitivity in vitro of a human hilus cell tumor.
Acta Obstet Gynecol Scand, 77 (1998), pp. 244-246
[20.]
G. Emons, O. Ortmann, G.S. Pahwa, U. Lohrs, T. Wetterling, H. Dilling, et al.
In vivo and in vitro effects of GnRH analogues on an ovarian Leydig cell tumour.
Geburtshilfe Frauenheilkd, 52 (1992), pp. 487-493
[21.]
R. Nakano, S. Kitayama, M. Yamoto, K. Shima, A. Ooshima.
Localization of gonadotropin binding site in human ovarian neoplasm.
Am J Obstet Gynecol, 161 (1989), pp. 905-910
[22.]
J.C. Cook, G.R. Klinefelter, J.F. Hardisty, R.M. Sharpe, P.M. Foster.
Rodent leydig cell tumorigenesis: a review of the physiology, pathology, mecanisms and relevance to humans.
Crit Rev Toxicol, 29 (1999), pp. 169-261
[23.]
M.C. Villares, A. Claudia, F. Marino, M.C. Zerbini, J.A. Miguel, L. Araujo, et al.
Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
J Clin Endocrinol Metab, 83 (1998), pp. 2074-2078
[24.]
L. Speroff, R.H. Glass, N.G. Kase.
Endocrinología ginecológica e infertilidad.
Buenos Aires, 6.a ed. 1.a ed. en castellano, pp. 487-522
[25.]
J. Calaf, J. Prat.
Mujer de 56 años con virilización.
Med Clin (Barc), 89 (1987), pp. 838-841
Copyright © 2001. Sociedad Española de Ginecología y Obstetricia